Admission Date:  [**2161-5-29**]       Discharge Date:  [**2161-7-9**]  Date of Birth:   [**2114-11-20**]       Sex:  M  Service:Transplant Surgery  ADDENDUM:  On [**2161-6-13**] the patient underwent orthotopic liver transplant with Drs.
The patient tolerated the procedure well with approximately 3,000 cc of crystalloid given intraoperatively, 14 units of fresh frozen plasma, three units of packed red cells, two units of platelets with an estimated blood loss of only 300 cc.
He remained intubated until postoperative day 14, which was [**2161-6-26**].
For immediate postoperative prophylaxis the patient was placed on Unasyn, valacyclovir, fluconazole, vancomycin, Zosyn and Bactrim.
Vancomycin was continued for a 16-day course, the Zosyn for a 10-day course.
At this point the patient was changed to acyclovir 800 mg t.i.d.
He was continued on vancomycin for this.
Fluids, electrolytes and nutrition:  Postoperatively the patient was begun on TPN for the first four postoperative days.
On postoperative day four the patient was begun on tube feeds for nutritional support.
Throughout his hospitalization he has remained on a Regular Insulin sliding scale.
At the time of discharge he was placed on glyburide 10 mg b.i.d.
At that point he was placed on a diet of nectar-thickened liquids and soft solids, to avoid thin liquids.
He remained intubated postoperatively until postoperative day seven at which point he was able to tolerate extubation and breathe on his own.
He was maintained on a regimen of hydralazine 20 mg p.o.
6 hours, clonidine patch for control of his hypertension.
The cardiology service was consulted for this and Lopressor was added to his regimen for rate control.
It was felt he may require ablation at some point postoperatively.
The first drain was removed on postoperative day 12, the second drain was removed on postoperative day 18.
Immediately postoperatively he was maintained on a Lasix drip for low urine output and diuresis following approximately a 20-liter net positive gain immediately postoperatively.
He was begun on a Solu-Medrol taper initially with 1 gram of Solu-Medrol given on postoperative day zero, slowly tapered down to 50 mg of Solu-Medrol by postoperative day six.
He remained on this until the time of discharge at which time he was changed to oral prednisone 15 mg p.o.
The patient was also begun on cyclosporine on postoperative day four.
Hepatology:  Initially the patient was maintained on a dose of hepatitis B immune globulin for the first six days postoperatively, at which point he was switched over to a q. week dosing.
At the time of discharge he has received two weeks of a four-week regimen of 10,000 units of hepatitis B immune globulin.
Additionally for hepatitis B the patient remained on adefovir 2 mg p.o.
He is to be discharged on this medication as well.
Encephalopathy status post intracranial pressure monitoring.
Adefovir dipivoxil 2 mg p.o.
Hydralazine 20 mg p.o.
Metoprolol 50 mg p.o.
Hepatitis B immune globulin 10,000 units IV q. Wednesday for two weeks.
Clonidine TTS patch, one patch transdermal q. Saturday.
Bactrim DS one tablet p.o.
Protonix 40 mg p.o.
Valcyte 450 mg p.o.
Fluconazole 400 mg p.o.
Glipizide 10 mg p.o.
CellCept 1,000 mg p.o.
Prednisone 15 mg p.o.
Cyclosporine 150 mg p.o.
